Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02820870 · ClinicalTrials.gov registry record · NA

Quality Improvement and Personalization for Statins

A NA study of Cardiovascular Disease, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
43
Enrollment target
1
Study location

NCT02820870 is a NA study of Cardiovascular Disease that has completed, run by VA Office of Research and Development. The registered enrollment target is 43 participants, below the 2,713-participant average among 136 other Cardiovascular Disease trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02820870, a NA study of Cardiovascular Disease, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
43 participants
Enrollment target
1
Study location

Study Summary

The investigators developed novel quality improvement intervention consisting of a personalized decision support tool, an educational program, a performance measure, and an audit and feedback system to encourage the adoption of the VA/DoD guidelines for the use of statin medicines. The investigators then performed a cluster randomized trial of the intervention in a single clinic.

Conditions Studied

Interventions

  • BEHAVIORAL Statin Decision Support Intervention

Study Locations (1)

Michigan

  • VA Ann Arbor Healthcare System, Ann Arbor, MI - Ann Arbor

Trial Details

FieldValue
Enrollment Target 43 participants
Start Date 2016-03
Est. Completion 2016-10-01
Phase NA

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT02820870

The ClinicalTrials.gov registry entry for NCT02820870 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,713-participant average among 136 other Cardiovascular Disease trials with a reported enrollment target (98% lower). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cardiovascular Disease appearing as the primary indexed condition, and to 1 intervention - of which Statin Decision Support Intervention is the first listed.

NCT02820870 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT02820870 about?

NCT02820870 is a clinical study titled "Quality Improvement and Personalization for Statins". The investigators developed novel quality improvement intervention consisting of a personalized decision support tool, an educational program, a performance measure, and an audit and feedback system to encourage the adoption of the VA/DoD guidelines for the use of statin medicines. The investigators...

What is the current status of trial NCT02820870?

This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2016-03. Estimated completion is 2016-10-01.

What conditions does trial NCT02820870 study?

This clinical trial studies the following conditions: Cardiovascular Disease.

What interventions are being tested in trial NCT02820870?

The interventions under investigation include: Statin Decision Support Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT02820870?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02820870 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiovascular Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.